1 / 21

Soft Tissue Regeneration, Inc.™

Confidential. Soft Tissue Regeneration, Inc.™ . Biodegradable Scaffold to Regenerate the ACL. Presented to Connecticut Angel Guild. August 13, 2009. ACL Tear. Following an ACL Injury. Instability of knee. Damage to the knee structure. An impaired quality of life. Market.

gustav
Download Presentation

Soft Tissue Regeneration, Inc.™

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Confidential Soft Tissue Regeneration, Inc.™ Biodegradable Scaffold to Regenerate the ACL Presented to Connecticut Angel Guild August 13, 2009

  2. ACL Tear Soft Tissue Regeneration, Inc.

  3. Following an ACL Injury • Instability of knee. • Damage to the knee structure. • An impaired quality of life. Soft Tissue Regeneration, Inc.

  4. Market $2 Billion Opportunity • 550,000 ACL surgeries performed worldwide each year • 250,000 USA • 300,000 Internationally • Estimated product pricing ($4000) • Market growth is estimated to be 3% - active aging population. Soft Tissue Regeneration, Inc.

  5. MARKET NEED • ACL - most commonly injured ligament. • Cannot repair itself • Autografts • surgery to take tissue from a patient’s leg • damage healthy tissue • additional recovery time. • Allografts • Tissue from cadavers • Potential for rejection • Cannot be sterilized (disease, infection). Soft Tissue Regeneration, Inc.

  6. What Do We Offer? REGENERATE THE ACL Simpler Procedure No Risks Associated with an allograft Potential for faster recovery Eliminates 30-40 min of OR time Soft Tissue Regeneration, Inc.

  7. The L-C Ligament™ Artist Rendition Soft Tissue Regeneration, Inc.

  8. L-C Ligament Picture Soft Tissue Regeneration, Inc.

  9. Analogy - Works Like a Trellis Soft Tissue Regeneration, Inc.

  10. The Solution: L-C Ligament ™ • Works exactly like, BUT eliminates the problems of Autografts and Allographs • Provides mechanical strength while ligament regenerates • Encourages ligament tissue to regenerate • Biocompatible and Biodegradable Soft Tissue Regeneration, Inc.

  11. Animal Study Rabbit Model Study for ACL Reconstruction Study published 2007, in PNAS “The histological and mechanical evaluation demonstrated excellent healing and regeneration with the L-C Ligament™.” Large Animal study Large animal study involving up to 60 sheep was started in early May at the University of New South Wales in Sydney Australia Soft Tissue Regeneration, Inc.

  12. Same Method of ACL Reconstruction Soft Tissue Regeneration, Inc.

  13. Surgical Technique Soft Tissue Regeneration, Inc.

  14. Surgical Technique Soft Tissue Regeneration, Inc.

  15. Fixation Soft Tissue Regeneration, Inc.

  16. Intellectual Property Patented Worldwide exclusive license of patent from Drexel University Proprietary Technology Device made using a special patented braiding machine FDA Process Pre Market Approval Soft Tissue Regeneration, Inc.

  17. Management Joseph W. Reilly, President and CEO Proven CEO/Entrepreneur Cato T. Laurencin, M.D., Ph.D., Founder, CSO Dean of the Medical School at UCONN and Vice President of the UConn Health Center in Farmington, CT Mark T. Aronson, Ph.D., Senior Scientist Assistant Professor of Chemical Engineering at UVA Lakshmi Nair, Ph.D., Senior Scientist Assistant Professor of Orthopaedic Surgery at UCONN Soft Tissue Regeneration, Inc.

  18. Scientific Advisory Board • Clarence Shields, M.D. – Chairman of the SAB Kerlan-Jobe Orthopaedic Center in California previous President of the American Orthopaedic Society for Sports Medicine (AOSSM). James R. Andrews, M.D. Internationally known and recognized throughout the world for his scientific and clinic research contributions and his skill as an orthopaedic surgeon. Robert S. Langer, Sc.D. Institute Professor at the MIT and internationally renowned biotechnology expert. Kenneth R. Alleyne, M.D. Orthopaedic surgeon specializing in sports medicine David W. Anderson President and CEO Gentis Inc. Successful serial entrepreneur in the Medical Device field. Soft Tissue Regeneration, Inc.

  19. Milestones Soft Tissue Regeneration, Inc.

  20. Summary Regeneration of the ACL $2 Billion Opportunity • Raising $3.5 million – Series A • $1,250,000 - MentorTech Ventures • $750,000 - Connecticut Innovations Need $1.5 million Soft Tissue Regeneration, Inc.

  21. Thank you Joseph W. Reilly • President and CEO • Tel: 203-539-6233 • Cell: 973-879-6367 • jwreilly@SoftTissueRegeneration.com Thank you! Soft Tissue Regeneration, Inc.

More Related